Novo Nordisk's (NVO) corrections amid AI market rotation might be an opportunity, due to GLP-1 market leadership & balanced ...

Discover OXSQH's 7.75% yield and investment-grade quality. With well-covered payments and a 20-year dividend history, it's a ...

Eldorado's stock has performed exceptionally well this year, rising more than 50% on the back of gold's momentum and Skouries ...

Super investors like Buffett and Michael Bury piled heavily into UnitedHealthcare in Q2, signalling confidence that the ...

Crescent Capital BDC posted strong Q2 income and dividend coverage, yet trades at a steep 21% NAV discount despite solid ...

Afya's Q2 2025 results were solid, but the stock faces headwinds from market saturation and regulatory changes in Brazil's ...

BP delivered strong Q2 results, beating earnings and revenue estimates due to strong profitability in its core business.

T-Mobile debuts investment-grade baby bonds (TMUSZ, TMUSL, TMUSI) maturing 2069–2070. Explore yields up to 6.22% and strong ...

Cencora (COR) directors agrees to a $111M cash payment to resolve claims by pension funds that their policies were inadequate ...

The real assets portfolio was the primary detractor due to negative returns for energy stocks and U.S. real estate investment ...

Tonix's Tonmya received FDA approval, marking the first new fibromyalgia therapy in 15 years and driving a post-market stock ...

Mid-America Apartment Communities has an attractive 4.3% yield, solid income prospects, and a favorable rate outlook. Read ...